Munster, S. K., White, V. L., Hutchings, D. C., Burian, D. M., & Nicholson, S. J. (2018). Comparison Study of Microarray and RNA-seq for Differential Expression (Report No. DOT/FAA/AM-20/09). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/57069
Munster, Susan K., Vicky L. White, David C. Hutchings, Dennis M. Burian, and Scott J. Nicholson. Comparison Study of Microarray and RNA-seq for Differential Expression. Report no. DOT/FAA/AM-20/09. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2018. https://rosap.ntl.bts.gov/view/dot/57069.
Munster, Susan K., et al. Comparison Study of Microarray and RNA-seq for Differential Expression. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2018, Report no. DOT/FAA/AM-20/09, ROSA P. https://rosap.ntl.bts.gov/view/dot/57069.
As costs for performing RNA-seq approach the costs affiliated with utilizing microarray technology, it is worthwhile to determine which methodology is the most efficient, cost effective, and accurate. In this study, we examined the relative capacities of microarrays and total RNA-seq to detect differential gene expression between total RNA samples containing the following RNA mixtures: blood, brain, 2:1 blood:brain, and 1:2 blood:brain. Two microarray hybridization library amplification methods were compared to optimize microarray results, which were then compared to total RNA-seq results for the same samples. Bioinformatic analysis was performed using commonly accepted analysis software for microarray and RNA-seq data to determine which method produced the greatest number of significant differentially expressed genes. It was determined that total RNA-seq outperformed microarrays in efficiency, result quality, and total numbers of detected genes and that cost was similar to utilizing microarrays for quantifying RNA expression levels from mixtures of brain and blood tissue.
Content Notes:
CAMI Aerospace Medical Research Division Project No. 2017-AAM-612-GEN-10020
Munster, S. K., White, V. L., Hutchings, D. C., Burian, D. M., & Nicholson, S. J. (2018). Comparison Study of Microarray and RNA-seq for Differential Expression (Report No. DOT/FAA/AM-20/09). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/57069
Munster, Susan K., Vicky L. White, David C. Hutchings, Dennis M. Burian, and Scott J. Nicholson. Comparison Study of Microarray and RNA-seq for Differential Expression. Report no. DOT/FAA/AM-20/09. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2018. https://rosap.ntl.bts.gov/view/dot/57069.
Munster, Susan K., et al. Comparison Study of Microarray and RNA-seq for Differential Expression. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2018, Report no. DOT/FAA/AM-20/09, ROSA P. https://rosap.ntl.bts.gov/view/dot/57069.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.